Rahman A, Jackson H, Hristov H, Isaacson RS, Saif N, Shetty T, et al. Sex and gender driven modifiers of Alzheimer’s: the role for estrogenic control across age, race, medical, and lifestyle risks. Front Aging Neurosci. 2019;11:315.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Riedel BC, Thompson PM, Brinton RD. Age, APOE and sex: triad of risk of Alzheimer’s disease. J Steroid Biochem Mol Biol. 2016;160:134–47.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Raulin AC, Doss SV, Trottier ZA, Ikezu TC, Bu G, Liu CC. ApoE in Alzheimer’s disease: pathophysiology and therapeutic strategies. Mol Neurodegener. 2022;17(1):72.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Rueter J, Rimbach G, Huebbe P. Functional diversity of apolipoprotein E: from subcellular localization to mitochondrial function. Cell Mol Life Sci. 2022;79(9):499.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Tai LM, Thomas R, Marottoli FM, Koster KP, Kanekiyo T, Morris AW, et al. The role of APOE in cerebrovascular dysfunction. Acta Neuropathol. 2016;131(5):709–23.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Parhizkar S, Holtzman DM. APOE mediated neuroinflammation and neurodegeneration in Alzheimer’s disease. Semin Immunol. 2022;59:101594.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Friedberg JS, Aytan N, Cherry JD, Xia W, Standring OJ, Alvarez VE, et al. Associations between brain inflammatory profiles and human neuropathology are altered based on apolipoprotein E epsilon4 genotype. Sci Rep. 2020;10(1):2924.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Reale M, Kamal MA, Velluto L, Gambi D, Di Nicola M, Greig NH. Relationship between inflammatory mediators, Abeta levels and ApoE genotype in Alzheimer disease. Curr Alzheimer Res. 2012;9(4):447–57.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ringman JM, Elashoff D, Geschwind DH, Welsh BT, Gylys KH, Lee C, et al. Plasma signaling proteins in persons at genetic risk for Alzheimer disease: influence of APOE genotype. Arch Neurol. 2012;69(6):757–64.

Article  PubMed  PubMed Central  Google Scholar 

Tzioras M, Davies C, Newman A, Jackson R, Spires-Jones T. Invited review: APOE at the interface of inflammation, neurodegeneration and pathological protein spread in Alzheimer’s disease. Neuropathol Appl Neurobiol. 2019;45(4):327–46.

Article  CAS  PubMed  Google Scholar 

Stephen TL, Cacciottolo M, Balu D, Morgan TE, LaDu MJ, Finch CE, et al. APOE genotype and sex affect microglial interactions with plaques in Alzheimer’s disease mice. Acta Neuropathol Commun. 2019;7(1):82.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Rodriguez GA, Tai LM, LaDu MJ, Rebeck GW. Human APOE4 increases microglia reactivity at Abeta plaques in a mouse model of Abeta deposition. J Neuroinflammation. 2014;11(1):111.

Article  PubMed  PubMed Central  Google Scholar 

Liu CC, Zhao N, Fu Y, Wang N, Linares C, Tsai CW, et al. ApoE4 accelerates early seeding of amyloid pathology. Neuron. 2017;96(5):1024-32 e3.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zhu Y, Nwabuisi-Heath E, Dumanis SB, Tai LM, Yu C, Rebeck GW, et al. APOE genotype alters glial activation and loss of synaptic markers in mice. Glia. 2012;60(4):559–69.

Article  PubMed  PubMed Central  Google Scholar 

Stephen TL, Breningstall B, Suresh S, McGill CJ, Pike CJ. APOE genotype and biological sex regulate astroglial interactions with amyloid plaques in Alzheimer’s disease mice. J Neuroinflammation. 2022;19(1):286.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Vitek MP, Brown CM, Colton CA. APOE genotype-specific differences in the innate immune response. Neurobiol Aging. 2009;30(9):1350–60.

Article  CAS  PubMed  Google Scholar 

Vitek MP, Christensen DJ, Wilcock D, Davis J, Van Nostrand WE, Li FQ, et al. APOE-mimetic peptides reduce behavioral deficits, plaques and tangles in Alzheimer’s disease transgenics. Neurodegener Dis. 2012;10(1–4):122–6.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Moser VA, Workman MJ, Hurwitz SJ, Lipman RM, Pike CJ, Svendsen CN. Microglial transcription profiles in mouse and human are driven by APOE4 and sex. iScience. 2021;24(11):103238.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Balu D, Karstens AJ, Loukenas E, Maldonado Weng J, York JM, Valencia-Olvera AC, et al. The role of APOE in transgenic mouse models of AD. Neurosci Lett. 2019;707:134285.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Melchiorri D, Merlo S, Micallef B, Borg JJ, Drafi F. Alzheimer’s disease and neuroinflammation: will new drugs in clinical trials pave the way to a multi-target therapy? Front Pharmacol. 2023;14:1196413.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Rivers-Auty J, Mather AE, Peters R, Lawrence CB, Brough D. Anti-inflammatories in Alzheimer’s disease-potential therapy or spurious correlate? Brain Commun. 2020;2(2):fcaa109.

Article  PubMed  PubMed Central  Google Scholar 

Hampel H, Caraci F, Cuello AC, Caruso G, Nistico R, Corbo M, et al. A path toward precision medicine for neuroinflammatory mechanisms in Alzheimer’s disease. Front Immunol. 2020;11:456.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Fu WY, Wang X, Ip NY. Targeting neuroinflammation as a therapeutic strategy for Alzheimer’s disease: mechanisms, drug candidates, and new opportunities. ACS Chem Neurosci. 2019;10(2):872–9.

Article  CAS  PubMed  Google Scholar 

Bruno K, Woller SA, Miller YI, Yaksh TL, Wallace M, Beaton G, et al. Targeting toll-like receptor-4 (TLR4)-an emerging therapeutic target for persistent pain states. Pain. 2018;159(10):1908–15.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Vaure C, Liu Y. A comparative review of toll-like receptor 4 expression and functionality in different animal species. Front Immunol. 2014;5:316.

Article  PubMed  PubMed Central  Google Scholar 

Behzadi P, Garcia-Perdomo HA, Karpinski TM. Toll-like receptors: general molecular and structural biology. J Immunol Res. 2021;2021:9914854.

Article  PubMed  PubMed Central  Google Scholar 

Schaefer L. Complexity of danger: the diverse nature of damage-associated molecular patterns. J Biol Chem. 2014;289(51):35237–45.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Miron J, Picard C, Frappier J, Dea D, Theroux L, Poirier J. TLR4 Gene expression and pro-inflammatory cytokines in Alzheimer’s disease and in response to hippocampal deafferentation in rodents. J Alzheimers Dis. 2018;63(4):1547–56.

Article  CAS  PubMed  Google Scholar 

Walter S, Letiembre M, Liu Y, Heine H, Penke B, Hao W, et al. Role of the toll-like receptor 4 in neuroinflammation in Alzheimer’s disease. Cell Physiol Biochem. 2007;20(6):947–56.

Article  CAS  PubMed  Google Scholar 

Islam R, Rajan R, Choudhary H, Vrionis F, Hanafy KA. Gender differences in Alzheimer’s may be associated with TLR4-LYN expression in damage associated microglia and neuronal phagocytosis. J Cell Physiol. 2022.

Miron J, Picard C, Lafaille-Magnan ME, Savard M, Labonte A, Breitner J, et al. Association of TLR4 with Alzheimer’s disease risk and presymptomatic biomarkers of inflammation. Alzheimers Dement. 2019;15(7):951–60.

Article  PubMed  Google Scholar 

Balistreri CR, Grimaldi MP, Chiappelli M, Licastro F, Castiglia L, Listi F, et al. Association between the polymorphisms of TLR4 and CD14 genes and Alzheimer’s disease. Curr Pharm Des. 2008;14(26):2672–7.

Article  CAS  PubMed  Google Scholar 

Chen YC, Yip PK, Huang YL, Sun Y, Wen LL, Chu YM, et al. Sequence variants of toll like receptor 4 and late-onset Alzheimer’s disease. PLoS One. 2012;7(12):e50771.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Tai LM, Ghura S, Koster KP, Liakaite V, Maienschein-Cline M, Kanabar P, et al. APOE-modulated Abeta-induced neuroinflammation in Alzheimer’s disease: current landscape, novel data and future perspective. J Neurochem. 2015;133(4):465–88.

Article  CAS  PubMed  PubMed Central